Division of Cardiovascular and Renal Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland

Correspondence: Dr. Aliza Thompson, Center for Drug Evaluation and Research, Food and Drug Administration, White Oak Campus, Building 22, Room 4116, 10903 New Hampshire Avenue, Silver Spring, MD 20993. Email: [email protected]